威门药业 (430369.OC)

+ 收藏

利润表(威门药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年中报2022年年报2022年三季报2022年中报2022年一季报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 138,616,220.47510,695,090.57320,300,868.84187,947,333.3460,309,043.22
 营业收入(元) 138,616,220.47510,695,090.57320,300,868.84187,947,333.3460,309,043.22
二、营业总成本(元) 142,797,665.72438,383,415.32279,679,319.96174,011,874.8569,726,750.98
 营业成本(元) 34,278,351.25106,327,237.8166,180,838.0740,467,966.8012,372,447.03
 研发费用(元) 2,346,850.609,217,061.592,616,138.421,599,359.591,524,212.19
 营业税金及附加(元) 4,378,961.368,138,489.205,330,827.173,554,826.111,536,936.77
 销售费用(元) 86,600,657.64280,816,577.68182,809,387.68114,343,636.9345,010,001.58
 管理费用(元) 13,884,358.7432,187,938.5422,391,859.6115,457,220.237,754,311.76
 财务费用(元) 1,308,486.131,696,110.50350,269.01-1,411,134.811,528,841.65
  其中:利息费用(元) 1,392,084.111,978,373.29580,642.72-1,261,923.721,600,495.05
  其中:利息收入(元) 111,146.48349,872.73278,313.24180,098.7990,092.42
三、其他经营收益
 资产减值损失(元) --814,735.61-111,037.40-289,089.95418,746.25
 信用减值损失(元) 5,235,703.77-7,866,350.13-1,978,199.60-376,550.03770,088.25
 其他收益(元) 2,917,562.6011,595,665.1810,087,246.919,404,258.47628,092.01
四、营业利润(元) 3,971,821.1275,226,254.6948,619,558.7922,674,076.98-7,600,781.25
 加:营业外收入(元) 108,416.38746.15210.10210.10-
 减:营业外支出(元) 101,417.49539,458.89574,954.89339,454.69131,981.08
五、利润总额(元) 3,978,820.0174,687,541.9548,044,814.0022,334,832.39-7,732,762.33
 减:所得税费用(元) 1,809,292.5313,396,524.118,930,225.354,197,007.89390,089.87
六、净利润(元) 2,169,527.4861,291,017.8439,114,588.6518,137,824.50-8,122,852.20
(一)按经营持续性分类
  持续经营净利润(元) 2,169,527.4861,291,017.8439,114,588.6518,137,824.50-8,122,852.20
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 2,169,527.4861,291,017.8439,114,588.6518,137,824.50-8,122,852.20
 扣除非经常性损益后的净利润(元) -316,349.7951,761,640.1430,930,700.0010,366,801.70-8,603,280.27
七、每股收益
 一、基本每股收益(元) 0.020.490.310.14-0.06
 二、稀释每股收益(元) 0.020.490.310.14-0.06
九、综合收益总额(元) 2,169,527.4861,291,017.8439,114,588.6518,137,824.50-8,122,852.20
 归属于母公司所有者的综合收益总额(元) 2,169,527.4861,291,017.8439,114,588.6518,137,824.50-8,122,852.20
公告日期 2023-08-282023-02-012022-11-032022-08-302022-06-02
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院